Modification of DNA by mitomycin C in cancer patients detected by 32P-postlabeling analysis
- PMID: 2847037
- DOI: 10.1016/0027-5107(88)90167-4
Modification of DNA by mitomycin C in cancer patients detected by 32P-postlabeling analysis
Abstract
DNA adducts of mitomycin C (MMC) were detected by 32P-postlabeling analysis in both surgical specimens and an autopsy sample of the liver of patients with hepatocellular carcinoma who had received chemotherapy with MMC. Four kinds of adducts were detected in all 6 patients treated with MMC. These adducts had identical chromatographic mobilities to those of adducts in the liver of rats treated with MMC, but 1 additional adduct was detected in rat liver. In patients treated with MMC, about 3 adducts/10(8) nucleotides were found 4 days after MMC treatment, and 1 adduct/10(8) nucleotides 14 days after treatment and the latter level was maintained for up to 56 days. MMC-DNA adducts were also detected in peripheral blood leukocytes from a patient 1 and 7 days after MMC treatment, at levels of 1 and 0.6 adduct/10(8) nucleotides, respectively. These results suggest the tumor-initiating activity of MMC in humans.
Similar articles
-
32P-analysis of DNA adducts in somatic and reproductive tissues of rats treated with the anticancer antibiotic, mitomycin C.Mutat Res. 1987 Jul;179(1):75-88. doi: 10.1016/0027-5107(87)90043-1. Mutat Res. 1987. PMID: 3110608
-
Detection of mitomycin C-DNA adducts in vivo by 32P-postlabeling: time course for formation and removal of adducts and biochemical modulation.Cancer Res. 1998 Feb 1;58(3):453-61. Cancer Res. 1998. PMID: 9458089
-
Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells.Mol Pharmacol. 1993 Jun;43(6):870-7. Mol Pharmacol. 1993. PMID: 8316219
-
32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.J UOEH. 1989 Mar 20;11 Suppl:368-86. J UOEH. 1989. PMID: 2664950 Review.
-
Monitoring carcinogen actions on DNA by 32P-postlabeling.Princess Takamatsu Symp. 1990;21:317-28. Princess Takamatsu Symp. 1990. PMID: 2134685 Review.
Cited by
-
DNA adducts as exposure biomarkers and indicators of cancer risk.Environ Health Perspect. 1997 Jun;105 Suppl 4(Suppl 4):907-12. doi: 10.1289/ehp.97105s4907. Environ Health Perspect. 1997. PMID: 9255579 Free PMC article. Review.
-
Human DNA adduct measurements: state of the art.Environ Health Perspect. 1996 Oct;104 Suppl 5(Suppl 5):883-93. doi: 10.1289/ehp.96104s5883. Environ Health Perspect. 1996. PMID: 8933030 Free PMC article. Review.
-
Platinum drug-DNA interactions in human tissues measured by cisplatin-DNA enzyme-linked immunosorbent assay and atomic absorbance spectroscopy.Environ Health Perspect. 1993 Mar;99:149-54. doi: 10.1289/ehp.9399149. Environ Health Perspect. 1993. PMID: 8319613 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources